Robert Bast
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
autophagy 12 (1), 1-222, 2016
The biology of cancer
RA Weinberg
Garland science, 2013
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
L Harris, H Fritsche, R Mennel, L Norton, P Ravdin, S Taube, ...
Journal of clinical oncology 25 (33), 5287-5312, 2007
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
RC Bast Jr, TL Klug, ES John, E Jenison, JM Niloff, H Lazarus, ...
New England journal of medicine 309 (15), 883-887, 1983
Reactivity of a monoclonal antibody with human ovarian carcinoma.
RC Bast, M Feeney, H Lazarus, LM Nadler, RB Colvin, RC Knapp
The Journal of clinical investigation 68 (5), 1331-1337, 1981
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
GY Locker, S Hamilton, J Harris, JM Jessup, N Kemeny, JS Macdonald, ...
Journal of clinical oncology 24 (33), 5313-5327, 2006
Principles and practice of pediatric oncology
PA Pizzo, DG Poplack
Lippincott Williams & Wilkins, 2015
The biology of ovarian cancer: new opportunities for translation
RC Bast, B Hennessy, GB Mills
Nature Reviews Cancer 9 (6), 415-428, 2009
The CA 125 tumour-associated antigen: a review of the literature
I Jacobs, RC Bast Jr
Human reproduction 4 (1), 1-12, 1989
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Z Zhang, RC Bast, Y Yu, J Li, LJ Sokoll, AJ Rai, JM Rosenzweig, ...
Cancer research 64 (16), 5882-5890, 2004
Rethinking ovarian cancer: recommendations for improving outcomes
S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ...
Nature Reviews Cancer 11 (10), 719-725, 2011
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology
RC Bast, P Ravdin, DF Hayes, S Bates, H Fritsche, JM Jessup, N Kemeny, ...
Journal of clinical oncology 19 (6), 1865-1878, 2001
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer
A Berchuck, A Kamel, R Whitaker, B Kerns, G Olt, R Kinney, JT Soper, ...
Cancer research 50 (13), 4087-4091, 1990
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
RG Moore, DS McMeekin, AK Brown, P DiSilvestro, MC Miller, WJ Allard, ...
Gynecologic oncology 112 (1), 40-46, 2009
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
RG Moore, AK Brown, MC Miller, S Skates, WJ Allard, T Verch, ...
Gynecologic oncology 108 (2), 402-408, 2008
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers
DF Hayes, RC Bast, CE Desch, H Fritsche Jr, NE Kemeny, JM Jessup, ...
JNCI: Journal of the National Cancer Institute 88 (20), 1456-1466, 1996
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation
SJ Brandt, WP Peters, SK Atwater, J Kurtzberg, MJ Borowitz, RB Jones, ...
New England Journal of Medicine 318 (14), 869-876, 1988
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
X Fang, SX Yu, Y Lu, RC Bast, JR Woodgett, GB Mills
Proceedings of the National Academy of Sciences 97 (22), 11960-11965, 2000
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.
SE Kabawat, RC Bast Jr, AK Bhan, WR Welch, RC Knapp, RB Colvin
International journal of gynecological pathology: official journal of the …, 1983
JC Holland
Oxford University Press, 2010
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20